FDA approves 1st-of-its-kind breast cancer treatment
The FDA has granted accelerated approval to Etcamah (camizestrant), marking the first FDA approval of a cancer therapy guided by the detection of a resistance mutation in circulating tumor DNA before imaging tests show disease progression. Etcamah is used with a CDK4/6 inhibitor to treat certain adults with HR-positive, HER2-negative, locally advanced or metastatic breast […] The post FDA approves 1st-of-its-kind breast cancer treatment appeared first on Becker's Hospital Review | Hea...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.